NASDAQ:CADL

Candel Therapeutics Stock Forecast

etoro logo Buy CADL
*Your capital is at risk
$4.73
+0.0900 (+1.94%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of CADL
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Candel Therapeutics, Inc. stock upgraded from Strong Sell Candidate to Sell Candidate after Monday trading session
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Oct 31, 2025 Loss -12.08%

The Candel Therapeutics, Inc. stock price gained 1.94% on the last trading day (Monday, 17th Nov 2025), rising from $4.64 to $4.73. During the last trading day the stock fluctuated 8.62% from a day low at $4.58 to a day high of $4.98. The price has fallen in 6 of the last 10 days and is down by -9.39% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 261 thousand more shares were traded than the day before. In total, 799 thousand shares were bought and sold for approximately $3.78 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $4.60 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -5.30% during the next 3 months and, with a 90% probability hold a price between $4.35 and $6.06 at the end of this 3-month period.

CADL Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, November 13, 2025, and so far it has risen 2.60%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Candel Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.86 and $5.42. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Candel Therapeutics, Inc. stock

Candel Therapeutics, Inc. finds support from accumulated volume at $4.64 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.395 between high and low, or 8.62%. For the last week, the stock has had daily average volatility of 6.15%.

Candel Therapeutics, Inc. is oversold on RSI14 (22). Some stock may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CADL) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Candel Therapeutics, Inc. to open at $4.76, and during the day (based on 14 day Average True Range), to move between $4.57 and $4.89, which gives a possible trading interval of +/-$0.313 (+/-6.85%) up or down from last closing price. If Candel Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 6.85% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.64 (1.90%) than the resistance at $5.11 (7.93%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Candel Therapeutics, Inc. stock A Buy?

Candel Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -2.307 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $4.76 ( 0.669%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

CADL Performance

Trading levels for CADL

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 5.16 9.02%
R2 5.01 5.83%
R1 4.91 3.86%
Price 4.73
S1 4.61 -2.52%
S2 4.52 -4.49%
S3 4.37 -7.68%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.56 17.55%
R2 5.54 17.12%
R1 5.11 7.93%
Price 4.73
S1 4.64 -1.90%
S2 4.61 -2.54%
S3 0 -

FAQ

What is the symbol for Candel Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Candel Therapeutics, Inc. is CADL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Candel Therapeutics, Inc. Stock?
Candel Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Candel Therapeutics, Inc. Stock?
Candel Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Candel Therapeutics, Inc. Stock.

What's the current price of Candel Therapeutics, Inc. Stock?
As of the end of day on the Nov 17, 2025, the price of an Candel Therapeutics, Inc. (CADL) share was $4.73.

What is the 52-week high and low for Candel Therapeutics, Inc. Stock?
The 52-week high for Candel Therapeutics, Inc. Stock is $14.60 and the 52-week low is $3.83.

What is the market capitalization of Candel Therapeutics, Inc. Stock?
As of the Nov 17, 2025, the market capitalization of Candel Therapeutics, Inc. is 259.681M.

When is the next earnings date for Candel Therapeutics, Inc.?
The upcoming earnings date for Candel Therapeutics, Inc. is Mar 23, 2026.
Click to get the best stock tips daily for free!
ABOUT CANDEL THERAPEUTICS, INC.
Candel Therapeutics
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of hi...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE